From the Journals

RevitalVision Demonstrates Efficacy, Safety in Infantile Nystagmus

Positive clinical data shows improvement in visual function in patients with infantile nystagmus

Share

RevitalVision has published significant clinical findings regarding its digital therapeutic designed for infantile nystagmus in the British Journal of Ophthalmology. This study presents the inaugural randomized controlled evidence supporting the effectiveness of RevitalVision's FDA-cleared neuroplasticity-based visual training program in enhancing visual function among patients suffering from this congenital eye movement disorder. Infantile nystagmus is marked by involuntary eye oscillations that begin in early infancy.

Original Source(s)

RevitalVision Demonstrates Efficacy, Safety in Infantile Nystagmus

Positive clinical data shows improvement in visual function in patients with infantile nystagmus

  • by Conexiant News Staff

  • January 13, 2026

  • 1 min

Related Content

Lutein in Children: What Changed?

Six-month trial evaluates choroidal thickness and axial length

Artificial Intelligence: Looking at Large Language Models

Learn about how these programs can help private practices and their related caveats.

Lab Insider

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.